Introduction {#sec1-1}
============

Hemoglobin (Hb) D-Punjab \[β121(GH4) Glu→Gln; HBB: C.364G\>C\] is a Hb variant carrying an amino acid substitution at position 121 of the β-globin chain. It was also known as HbD-Los Angeles, HbD-North Carolina, HbD-Portugal, HbD-Chicago, and Hb Oak Ride.\[[@ref1]\] HbD-Punjab is quite prevalent in Pakistan, Northwest India, China, Middle East countries, and also in many other parts of the world with the overall frequency of 0.2%--3.0%.\[[@ref2][@ref3][@ref4]\] Both the heterozygote and homozygote for HbD-Punjab are clinically silent conditions. However, the coinheritance of HbD-Punjab with HbS \[β6(A3) Glu→Val; HBB: C.20A\>T\] results in mild clinical symptoms to severe conditions with sickle cell disease.\[[@ref5]\] Moreover, the coinheritance of HbD-Punjab with HbE \[β26(B8) Glu→Lys; HBB: C.79G\>A\] or with β^+^-thalassemia had been reported in Thai patients. The typical thalassemic indices with hypochromic microcytosis (mean corpuscular hemoglobin \[MCH\] 18.6--25.5 pg and mean corpuscular volume \[MCV\] 57.0--77.2 fL) were observed in these patients.\[[@ref1]\] The coinheritance of HbD-Punjab with β^0^-thalassemia is not common. There has been no report on the overall prevalence of coinheritance of HbD-Punjab with β^0^-thalassemia. However, the prevalence of compound heterozygosity for HbD-Punjab and β-thalassemia reported at the Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran from 2006 to 2011 was 0.6%,\[[@ref6]\] and a few cases of compound heterozygosity for HbD-Punjab and β^0^-thalassemia were reported in India, Saudi Arabia, and England.\[[@ref2][@ref4][@ref7]\] These cases had mild to severe anemia with hepatosplenomegaly, Hb values between 80 and 120 g/L, and typical thalassemic indices and morphological change of red cells. HbF values are slightly elevated (1%--7%) while HbA~2~ values are varied from 2.9% to 6.4%.\[[@ref2][@ref7]\] The normal value of HbA~2~ in a sample with coinheritance of HbD-Punjab and β^0^-thalassemia could result in the misdiagnosis of β-thalassemia carrier and inappropriate genetic counseling, as in the case reported by Belhoul *et al*.\[[@ref8]\] In this study, we reported for the first time of the coinheritance of HbD-Punjab with β^0^-thalassemia in a Thai girl.

Case Report {#sec1-2}
===========

A 7-year-old Thai girl was seen by a pediatrician at Hatyai Hospital, Songkhla, Thailand for annual health check-up. Her blood sample was collected with ethylenediaminetetraacetic acid as anticoagulant and the complete blood count was analyzed using an automated blood counter (Sysmex KX-21, Sysmex Corporation, Kobe, Japan). Values observed were white blood cell 5.89 × 10^9^ cells/L, red blood cell (RBC) 6.34 × 10^12^ cells/L, Hb 115.0 g/L, packed cell volume 0.33 L/L, MCV 52.5 fL, MCH 18.1 pg, MCH concentration 345 g/L, red cell distribution width 18.4%, and platelet 420 × 10^9^/L. Her blood sample was also sent to the Associated Medical Sciences Clinical Service Center, Chiang Mai University, Chiang Mai, Thailand, for the thalassemia diagnosis. In the thalassemia laboratory, the Hb analysis was performed using high-performance liquid chromatography (HPLC, VARIANT II, β-thalassemia Short Program, Bio-Rad Laboratories, Hercules, California, USA). The abnormal Hb peak with a value of 80.7% was observed in D-window at the retention time of 4.13 min while the levels of HbA, HbA~2~, and HbF were 5.1%, 3.2%, and 4.9%, respectively \[[Figure 1a](#F1){ref-type="fig"}\]. The Hb analysis was also performed by capillary electrophoresis (CE, Capillarys™ 2 Flex Piercing, Sebia, Norcross, Georgia, USA). On the CE electrophoregram, the abnormal Hb with a value of 81.9% was presented at a migration position of 180 s while the levels of HbA and HbA~2~ were 10.8% and 7.3%, respectively \[[Figure 1b](#F1){ref-type="fig"}\].

![The high-performance liquid chromatography chromatogram (a) and capillary electrophoresis electrophoregram (b) of the patient](AJTS-11-199-g001){#F1}

The real-time polymerase chain reaction (PCR) with SYBR Green1 and high resolution melting analysis for detection of the α-thalassemia-1 Southeast Asian and Thai type deletions\[[@ref9]\] was also performed in this sample and the negative analysis result was observed. The multiplex allele-specific-PCR was performed for molecular diagnosis of Hb Q-Thailand (HBA1: C.223G\>C) and three β-globin variants, including Hb Tak (HBB: C.441_442insAC), HbS (HBB: C.20A\>T), and HbD-Punjab because these Hb variants are eluted at the same retention time on HPLC chromatogram and have a similar migration position on CE electrophoregram.\[[@ref10]\] The 329 bp amplified fragment from the HbD-Punjab allele was observed \[[Figure 2a](#F2){ref-type="fig"}\]. The elevated HbA~2~(7.3%) was found on the CE electrophoregram. Therefore, the coinheritance of HbD-Punjab with β^0^-thalassemia was doubted. The β^0^-thalassemia codons 17 (A\>T), 41/42 (−TCTT), 71/72 (+A), and IVSI nt1 (G\>T) mutations were analyzed by the multiplex amplification refractory mutation system-PCR, whereas the β^0^-thalassemia 3.4 kb deletion was detected by the Gap-PCR, according to protocols described previously.\[[@ref11]\] The 490 bp amplified fragment of β^0^-thalassemia 3.4 kb deletion was observed \[[Figure 2b](#F2){ref-type="fig"}\]. Thus, the patient was finally diagnosed as coinheritance of HbD-Punjab with β^0^-thalassemia 3.4 kb deletion.

![Representative agarose gel electrophoresis for: (a) The allele-specific-polymerase chain reaction for detection of the hemoglobin D-Punjab. The produce fragments of 329 and 578 bp specific for hemoglobin D-Punjab and internal control fragment, respectively, are indicated. Lane 1: Hemoglobin D-Punjab carrier; Lane 2: normal control; Lane 3: the subject. M represents the GeneRuler 100 bp DNA ladder. (b) The Gap-polymerase chain reaction for detection of β^0^-thalassemia 3.4 kb deletion. The produce fragments of 490 and 578 specific for β^0^-thalassemia 3.4 kb deletion and internal control fragment, respectively, are indicated. Lane 1: β^0^-thalassemia 3.4 kb deletion positive control, Lane 2: normal control; Lane 3: the subject. M represents the GeneRuler 100 bp DNA ladder](AJTS-11-199-g002){#F2}

Discussion {#sec1-3}
==========

HbD-Punjab and β^0^-thalassemia 3.4 kb deletion are not common in Thailand. The prevalence of β^0^-thalassemia 3.4 kb deletion varies from 0.3% to 4.3%.\[[@ref9]\] Thus, this is the first case of coinheritance of HbD-Punjab with β^0^-thalassemia 3.4 kb deletion reported in a Thai subject. She had mild anemia with RBC microcytosis, but she did not have hepatosplenomegaly. Consistency with the previous study showed that cases with coinherited HbD-Punjab and β^0^-thalassemia had only mild to moderate anemia.\[[@ref2]\] In this study, the HbA~2~ level measured by HPLC was 3.2% which was in the reference ranges (\<3.5%). On HPLC chromatogram, the normal (3.3%) and elevated (6.4%) HbA~2~ levels had been reported in two siblings who coinherited HbD-Punjab with the same β^0^-thalassemia mutation (codon 30, AGG\>ACG).\[[@ref7]\] These results suggested that HbA~2~ level measured on HPLC which is used as a diagnostic marker for β-thalassemia trait is not a reliable parameter when differentiating homozygotes of HbD-Punjab and compound heterozygotes of HbD-Punjab and β^0^-thalassemia. However, the elevated HbA~2~(7.3%) was observed on the CE electrophoregram. On HPLC, HbD-Punjab elutes close to HbA~2~ generally lead to an underestimated HbA~2~ level. On CE, common Hb variants including HbS, HbC, HbD-Punjab, and HbE migrate separately from HbA~2~ and they do not interfere in the HbA~2~ quantification.\[[@ref12]\] Thus, CE is very efficient in separating and quantifying HbA~2~ and it is a reliable method for differentiating homozygotes of HbD-Punjab and compound heterozygotes of HbD-Punjab and β^0^-thalassemia.

Conclusion {#sec1-4}
==========

The coinheritance of HbD-Punjab with β^0^-thalassemia can be found in the Thai population. Therefore, a better understanding of HPLC chromatogram and CE electrophoregram patterns and clinical features of this combination is useful for genetic counseling, prevention, and control programs for thalassemia and hemoglobinopathy.

Financial support and sponsorship {#sec2-1}
---------------------------------

This work was supported by grant from University of Phayao, Phayao, Thailand.

Conflicts of interest {#sec2-2}
---------------------

There are no conflicts of interest.

The authors would like to thank technicians at the Hatyai Hospital, Songkhla, Thailand, for their help and assistance. We are also grateful to John Yargo, Faculty of Humanities, Chiang Mai University, Chiang Mai, Thailand, for refinement of English language.
